Surgical Devices · Aliso Viejo, CA · Founded 2019 · Publicly Held
SpyGlass Pharma Inc is a late-stage biopharmaceutical company focused on transforming the treatment paradigm for patients living with chronic eye conditions through long-acting, sustained drug… SpyGlass Pharma (NAS: SGP) is based in Aliso Viejo, CA and was founded in 2019. It is now publicly traded; this page covers its private-market history, where its last recorded valuation was $511 million (Feb 2026). It has raised $349 million across 2 recorded rounds; the latest was a $75 million Series D in Jun 2025.
Last price · $/share
—
Implied valuation
$510.6M
Total raised
$348.5M
Last round
Later Stage VC (Series D)
Jun 2025
Cap table — not yet on record
SpyGlass Pharma (NAS: SGP)'s share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of SpyGlass Pharma (NAS: SGP) with a free account
·Watch SpyGlass Pharma (NAS: SGP): the Monday email on marks, rounds and moves
Where does SpyGlass Pharma (NAS: SGP)'s cap table come from?
Share classes are assembled from certificates of incorporation, priced-round filings, and disclosures across SpyGlass Pharma (NAS: SGP)'s 2 recorded funding rounds.
